ITERION THERAPEUTICS

Iterion Therapeutics is a venture-backed, clinical-stage biotechnology company that develops novel targeted cancer therapeutics. The company’s lead product, Tegavivint, is a potent and selective inhibitor of the Wnt/b-catenin signaling pathway, implicated in cell proliferation, differentiation, immune evasion, and stem cell renewal. Tegavivint demonstrates pre-clinical in vivo efficacy in several cancer models including desmoid tumors, acute myeloid leukemia (AML), osteosarcoma, and a range of solid tumor types. The Company is currently enrolling a Phase I clinical study of Tegavivint in patients with desmoid tumors at multiple clinical centers in the United States and Canada. It was founded in 2010 and is headquartered in Houston, Texas.

#SimilarOrganizations #People #Financial #Website #More

ITERION THERAPEUTICS

Social Links:

Linkedin

Industry:

Biotechnology Pharmaceutical Therapeutics

Founded:

2010-01-01

Address:

Houston, Texas, United States

Country:

United States

Website Url:

http://www.iteriontherapeutics.com

Total Employee:

1+

Status:

Active

Total Funding:

21.38 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible Google Font API WordPress Wordpress Plugins Nginx PHP Contact Form 7 PHP 7 GoDaddy SSL

Similar Organizations

aimmune-therapeutics-logo

Aimmune Therapeutics

Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.

sov-therapeutics-logo

SOV Therapeutics

SOV Therapeutics is a clinical stage biotechnology company developing oral testosterone replacement therapies for adult men.

Current Employees Featured

alain-d-cappeluti_image

Alain D. Cappeluti
Alain D. Cappeluti CFO @ Iterion Therapeutics
CFO

sunil-sharma_image

Sunil Sharma
Sunil Sharma Co-Founder @ Iterion Therapeutics
Co-Founder
2010-12-01

stephen-k-horrigan_image

Stephen K. Horrigan
Stephen K. Horrigan Chief Scientific Officer @ Iterion Therapeutics
Chief Scientific Officer
2011-04-01

jean-chang_image

Jean Chang
Jean Chang Chief Operating Officer @ Iterion Therapeutics
Chief Operating Officer
2021-07-01

casey-cunningham_image

Casey Cunningham
Casey Cunningham CMO @ Iterion Therapeutics
CMO

rahul-aras_image

Rahul Aras
Rahul Aras President & CEO @ Iterion Therapeutics
President & CEO
2018-06-01

Founder

rahul-aras_image

Rahul Aras

stephen-k-horrigan_image

Stephen K. Horrigan

sunil-sharma_image

Sunil Sharma

Investors List

gpg-ventures_image

GPG Ventures

GPG Ventures investment in Series B - Iterion Therapeutics

sante-ventures_image

Sante Ventures

Sante Ventures investment in Series B - Iterion Therapeutics

lumira-ventures_image

Lumira Ventures

Lumira Ventures investment in Series B - Iterion Therapeutics

viva-biotech_image

Viva BioInnovator

Viva BioInnovator investment in Series B - Iterion Therapeutics

goose-society-of-texas_image

GOOSE Capital

GOOSE Capital investment in Series B - Iterion Therapeutics

cancer-prevention-and-research-institute-of-texas_image

Cancer Prevention and Research Institute of Texas

Cancer Prevention and Research Institute of Texas investment in Series B - Iterion Therapeutics

sante-ventures_image

Sante Ventures

Sante Ventures investment in Series B - Iterion Therapeutics

angel-md_image

AngelMD

AngelMD investment in Series B - Iterion Therapeutics

sante-ventures_image

Sante Ventures

Sante Ventures investment in Series A - Iterion Therapeutics

Official Site Inspections

http://www.iteriontherapeutics.com

Host Informations
Whois Informations

Loading ...

More informations about "Iterion Therapeutics" on Search Engine